Healthcare [ 13/13 ] | Biotechnology [ 127/164 ]
NASDAQ | Common Stock
Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China.
It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc.
In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution.
Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners.
The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023.
The company was incorporated in 2010 and is based in New York, New York.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Sep 14, 23 | -0.76 Decreased by -482.69% | - |
| May 16, 23 | -0.39 Increased by +61.39% | - |
| Dec 20, 22 | -3.60 Decreased by -823.33% | - |
| Sep 15, 22 | 0.00 Increased by +100.00% | - |
| May 16, 22 | -0.13 Increased by +81.94% | -0.10 Decreased by -30.00% |
| Oct 1, 21 | -1.01 Increased by +81.97% | -0.13 Decreased by -676.92% |
| Apr 30, 21 | -0.39 | -0.11 Decreased by -254.55% |
| Dec 2, 20 | -0.16 | -0.18 Increased by +11.11% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Mar 31, 23 | N/A - | N/A - | - - |
| Dec 31, 22 | 437.00 K - | -31.90 M - | Decreased by -7.30 K% - |
| Sep 30, 22 | 6.39 M - | -21.91 M - | Decreased by -342.73% - |
| Jun 30, 22 | 3.25 M - | -33.44 M - | Decreased by -1.03 K% - |